EMD 525797
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for EMD 525797, covering 2015-12-14 to 2017-08-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer [Phase 1]